Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
18,477,639
-
Share change
-
+829,765
-
Total reported value
-
$505,164,000
-
Price per share
-
$27.34
-
Number of holders
-
67
-
Value change
-
+$22,009,986
-
Number of buys
-
39
-
Number of sells
-
29
Institutional Holders of LOXO ONCOLOGY INC - COM (LOXO) as of Q1 2016
As of 31 Mar 2016,
LOXO ONCOLOGY INC - COM (LOXO) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,477,639 shares.
The largest 10 holders included
Aisling Capital LLC, FMR LLC, ORBIMED ADVISORS LLC, NEA Management Company, LLC, RS INVESTMENT MANAGEMENT CO LLC, EVENTIDE ASSET MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, DRIEHAUS CAPITAL MANAGEMENT LLC, and PointState Capital LP.
This page lists
67
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.